Molecular Partners Ag -adr Share Price

NASDAQ: MOLN

Small Cap

$3.72

-0.03

(-0.80%)

as on September 13, 2025 at 1:26 am IST

$₹

Molecular Partners Ag -adr Stock Performance

as on September 13, 2025 at 1:26 am IST

Day's High
$3.72
Day's Price Range
$3.74
$3.72
0.54%
Upside
52 Week's Low
52 Week's High
$3.36
52-Week Price Range
$7.6
$3.72
9.68%
Downside
104.30%
Upside

Molecular Partners Ag -adr share price movements today

Previous Close: $3.75
Open: $3.73
Volume: 109.2K
Day's Low - High: $3.72 - $3.74
52 Week Low - High: $3.36 - $7.6

Molecular Partners Ag -adr Historical Returns

1 Month Return: + 8.22 %
3 Month Return: + 0.26 %
1 Year Return: -26.25 %
3 Year Return: -36.64 %
5 Year Return: 0 %

Molecular Partners Ag -adr Stock Fundamentals & Key Indicators

Check Molecular Partners Ag -adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$140.2M

EPS (TTM)

-1.5107

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-59.3M

Revenue (TTM)

681.0K

Profit Margin

0.00%

Return On Equity TTM

48676600.00%

Molecular Partners Ag -adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Molecular Partners Ag -adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Molecular Partners Ag -adr	SELL	$140.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Molecular Partners Ag -adr Stock including INR - Dollar returns

The Molecular Partners Ag -adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Molecular Partners Ag -adr investment value today

Current value as on today

₹76,403

Returns

₹23,597

(-23.6%)

Returns from Molecular Partners Ag -adr Stock

₹28,736 (-28.74%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Molecular Partners Ag -adr Stock

Based on 11 analysts

SELL

9.09%

Buy

27.27%

Hold

63.64%

Sell

Based on 11 analysts, 63.64% of analysts recommend a 'SELL' rating for Molecular Partners Ag -adr. Average target price of $10.6

Molecular Partners Ag -adr Share Price Target

Get share price movements and forecasts by analysts on Molecular Partners Ag -adr.

What analysts predicted

64.91%UPSIDE

Target Price

$10.6

Current Price

$3.72

Analyzed by

11 Analysts

Target

$10.60

Molecular Partners Ag -adr target price $10.6, a slight upside of 64.91% compared to current price of $3.72. According to 11 analysts rating.

Molecular Partners Ag -adr Stock's Interest Amongst Investors

Search interest for Molecular Partners Ag -adr Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:100% versus previous 30 day period

Molecular Partners Ag -adr Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	0	2	1	3	1	0	-	-	-
Gross Profit	-10	-12	-10	-12	-12	-12	0	-	-	-
Operating Income	-15	-15	-13	-16	-15	-15	-14	-14	-16	-17
EBITDA	-14	-15	-10	-19	-10	-14	-15	-10	-16	-19
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-14	-15	-11	-19	-11	-15	-16	-11	-16	-20
Income Tax Expense	0	0	0	0	0	-	-	0	0	-
Net Income	-16	-17	-12	-22	-12	-16	-19	-12	-18	-20
Net Profit Margin	-502.39%	-3852.29%	-450.18%	-1916.67%	-413.62%	-972.40%	-2408.81%	0.00%	0.00%	0.00%

Molecular Partners Ag -adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	29	22	20	10	20	10	10	203	8	5
Gross Profit	28	8	2	-5	-23	-52	-50	148	-47	5
Operating Income	-2	-19	-25	-37	-36	-58	-63	116	-61	-61
EBITDA	0	-17	-24	-36	-33	-59	-60	117	-59	-51
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	1	0	2	2	2	2	2	2
Income Before Tax	0	-18	-25	-37	-36	-62	-63	117	-61	-54
Income Tax Expense	-1	0	0	0	0	0	0	0	2	0
Net Income	0	-18	-25	-37	-36	-70	-69	126	-71	-60
Net Profit Margin	-0.51%	-80.78%	-127.05%	-357.66%	-178.03%	-671.70%	-683.65%	62.17%	-880.70%	-1087.38%

Molecular Partners Ag -adr Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-15	-11	-19	-11	-15	-16	-11	-16	-20
Operating Cash Flow	-13	-13	-14	-15	-14	-13	-13	-17	-13
Investing Cash Flow	4	17	18	16	11	14	-4	34	14
Financing Cash Flow	0	0	0	0	0	0	15	0	0
Change in Cash	-10	5	-19	-12	-15	0	-1	17	0

Molecular Partners Ag -adr Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-25	-37	-36	-62	-63	117	-61	-54
Operating Cash Flow	-35	-40	-42	-1	-28	-90	118	-59	-59
Investing Cash Flow	-11	20	9	-19	-21	-22	-101	44	40
Financing Cash Flow	0	0	0	0	113	50	-1	-1	14
Change in Cash	-45	-18	-32	-23	58	-61	16	-20	-3

Global Institutional Holdings in Molecular Partners Ag -adr

Funds	Holdings
Suvretta Capital Management, LLC	6.02%
Bvf Inc	3.67%
UBS Group AG	0.02%
Morgan Stanley - Brokerage Accounts	0%
Rhumbline Advisers	0%

See all

Insights on Molecular Partners Ag -adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 163.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 103.9%
NEGATIVE IMPACT
Price Dip
In the last 6 months, MOLN stock has moved down by -14.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.73M → 681.0K (in $), with an average decrease of 49.7% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -11.23M → -20.39M (in $), with an average decrease of 35.5% per quarter

About Molecular Partners Ag -adr

Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Organisation	Molecular Partners Ag -adr
Headquarters	Wagistrasse 14, Schlieren, Switzerland, 8952
Industry	Services
CEO	Dr. Patrick Amstutz Ph.D.
E-voting on shares	Click here to vote

Key Management of Molecular Partners Ag -adr

Name	Title
Mr. Daniel Steiner Ph.D.	Senior Vice President of Research & Technology
Mr. Michael Pitzner	General Counsel, Compliance Officer, Senior VP Legal & Business Development
Dr. Patrick Amstutz Ph.D.	Co-Founder, CEO, Member of Management Board & Director
Dr. Michael Tobias Stumpp Ph.D.	Co-Founder, Executive VP of Projects & Member of Management Board
Mr. Alexander Zurcher	COO & Member of Management Board
Ms. Renate Gloggner	Executive VP of People & Community and Member of Management Board
Mr. Robert Hendriks	Senior VP of Finance
Dr. Philippe Legenne M.B.A., M.D.	Chief Medical Officer & Member of the Management Board
Mr. Seth D. Lewis	Senior Vice President of Investor Relations, Communications & Strategy
Dr. Pamela A. Trail Ph.D.	Strategic Consultant

FAQs

What is Molecular Partners Ag -adr share price today?

Molecular Partners Ag -adr share price today is $3.72 as on September 13, 2025 at 1:26 am IST at the close of the market. Molecular Partners Ag -adr share today touched a day high of $3.74 and a low of $3.72.

What is the 52 week high and 52 week low for Molecular Partners Ag -adr share?

Molecular Partners Ag -adr share touched a 52 week high of $7.6 on October 22, 2024 and a 52 week low of $3.36 on April 29, 2025. Molecular Partners Ag -adr stock price today i.e. September 13, 2025 at 1:26 am IST is closed at $3.72,which is 51.05% down from its 52 week high and 10.71% up from its 52 week low.

What is Molecular Partners Ag -adr's market capitalisation today?

Molecular Partners Ag -adr market capitalisation is $0.00T as on September 13, 2025 at 1:26 am IST.

How to invest in Molecular Partners Ag -adr Stock (MOLN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Molecular Partners Ag -adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Molecular Partners Ag -adr Shares that will get you 0.4032 shares as per Molecular Partners Ag -adr share price of $3.72 per share as on September 13, 2025 at 1:26 am IST.

What is the minimum amount required to buy Molecular Partners Ag -adr Stock (MOLN) from India?

Indian investors can start investing in Molecular Partners Ag -adr (MOLN) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 4:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Molecular Partners Ag -adr stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 4:39 am IST). Based on Molecular Partners Ag -adr share’s latest price of $3.72 as on September 13, 2025 at 1:26 am IST, you will get 2.6882 shares of Molecular Partners Ag -adr. Learn more about fractional shares .